# VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C

> **NCT02823457** · NA · COMPLETED · sponsor: **G.V. (Sonny) Montgomery VA Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders

## Interventions

- **BEHAVIORAL:** VBMI

## Key facts

- **NCT ID:** NCT02823457
- **Lead sponsor:** G.V. (Sonny) Montgomery VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823457, "VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02823457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*